Abstract
Purpose
Bayesian optimization has been studied in many fields as a technique for global optimization of black-box functions. We applied these techniques for optimizing the formulation and manufacturing methods of pharmaceutical products to eliminate unnecessary experiments and accelerate method development tasks.
Method
A simulation dataset was generated by the data augmentation from a design of experiment (DoE) which was executed to optimize the formulation and process parameters of orally disintegrating tablets. We defined a composite score for integrating multiple objective functions, physical properties of tablets, to meet the pharmaceutical criteria simultaneously. Performance measurements were used to compare the influence of the selection of initial training sets, by controlling data size and variation, acquisition functions, and schedules of hyperparameter tuning. Additionally, we investigated performance improvements obtained using Bayesian optimization techniques as opposed to random search strategy.
Results
Bayesian optimization efficiently reduces the number of experiments to obtain the optimal formulation and process parameters from about 25 experiments with DoE to 10 experiments. Repeated hyperparameter tuning during the Bayesian optimization process stabilizes variations in performance among different optimization conditions, thus improving average performance.
Conclusion
We demonstrated the elimination of unnecessary experiments using Bayesian optimization. Simulations of different conditions depicted their dependencies, which will be useful in many real-world applications. Bayesian optimization is expected to reduce the reliance on individual skills and experiences, increasing the efficiency and efficacy of optimization tasks, expediting formulation and manufacturing research in pharmaceutical development.
Similar content being viewed by others
Abbreviations
- ANN:
-
Artificial neural network
- DoE:
-
Design of experiment
- TS:
-
Tensile strength
- TM replaces TS:
-
Thompson sampling
References
Box GEP, Wilson KB. On the experimental attainment of optimum conditions Breakthroughs in statistics: methodology and distribution (2012): 270.
Sano S, Iwao Y, Kimura S, Itai S. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation. Int J Pharm. 2011;416:252–9.
Awotwe-Otoo D, Agarabi C, Wu GK, Casey E, Read E, Lute S, et al. Quality by design: iImpact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. Int J Pharm. 2012;438:167–75.
Takayama K, Fujikawa M, Obata Y, Morishita M. Neural network based optimization of drug formulations. Adv Drug Deliv Rev. 2003;55:1217–31.
Wu T, Pan W, Chen J, Zhang R. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets. Drug Dev Ind Pharm. 2000;26:211–5.
Li YF, Venkatasubramanian V. Neural network to understand process capability and process intermediates acceptance criteria in monoclonal antibody production process. J Pharm Innov. 2018;13:36–47.
Arai H, Suzuki T, Kaseda C, Ohyama K, Takayama K. Bootstrap re-sampling technique to evaluate the optimal formulation of theophylline tablets predicted by non-linear response surface method incorporating multivariate spline interpolation. Chem Pharm Bull. 2007;55:586–93.
Bergstra JJ, Yoshua Bengio Yoshuabengio U. Random search for hyper-parameter optimization. J Mach Learn Res. 2012;13:281–305.
Jones DR, Schonlau M, Welch WJ. Efficient global optimization of expensive black-box functions. J Glob Optim. 1998;13:455–92.
Snoek J, Larochelle H, Adams RP. Practical Bayesian optimization of machine learning algorithms. Adv Neural Inf Proces Syst. 2012;25:2951–9.
Harold JK. A new method for locating the maximum point of an arbitrary multipeak curve in the presence of noise. J Basic Eng. 1964;86:07–106.
Mockus J, Tiesis V, Zilinskas A. The application of Bayesian methods for seeking the extremum. L. Dixon, G. Szego Eds. Towards Global Optimization; 1978.
Auer P. Using confidence bounds for exploitation-exploration trade-offs. J Mach Learn Res. 2003;3:397–422.
Zukerman I, Zukerman I, Albrecht DW, Albrecht DW, Zhou L, White JM, et al. Monte Carlo methods. Mach Learn. 2007;1:1–123.
Srinivas N, Krause A, Kakade SM, Seeger M. Information-theoretic regret bounds for Gaussian process optimization in the bandit setting. IEEE Tr Inf Theo. 2012;58:3250–65.
Chapelle O, Li L. An empirical evaluation of Thompson sampling. Adv Neural Inf Proces Syst. 2011;24:2249–57.
Boukouvala F, Ierapetritou MG. Feasibility analysis of black-box processes using an adaptive sampling Kriging-based method. Comput Chem Eng. 2012;36:358–68.
Rogers A, Ierapetritou M. Feasibilityand flexibility analysis of black-box processes Part 1: Surrogate-based feasibility analysis. Chem Eng Sci. 2015;137:986–1004.
Rogers A, Ierapetritou M. Feasibility and flexibility analysis of black-box processes Part 2: Surrogate-based feasibility analysis. Chem Eng Sci. 2015;137:1005–13.
Wang Z, Ierapetritou M. A novel feasibility analysis method for black-box processes using a radial basis function adaptive sampling approach. J AIChE. 2017;63(2):532–50.
Yoshinari T, Forbes RT, York P, Kawashima Y. Moisture induced polymorphic transition of mannitol and its morphological transformation. Int J Pharm. 2002;247:69–77.
Yoshinari T, Forbes RT, York P, Kawashima Y. The improved compaction properties of mannitol after a moisture-induced polymorphic transition. Int J Pharm. 2003;258:121–31.
Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull. 2004;52:704–7.
Harada T, Narazaki R, Nagira S, Ohwaki T, Aoki S, Iwamoto K. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull. 2006;54:1072–5.
Sano S, Iwao Y, Noguchi S, Kimura S, Itai S. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol. Int J Pharm. 2013;448:132–41.
R Core Team. R: aA language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. https://www.R-project.org/
Frauke G, Stefan F. Neuralnet: Training of neural networks. The R Journal 2010;2:30–38.
Ueno T, Rhone TD, Hou Z, Mizoguchi T, Tsuda K. COMBO: aAn efficient Bayesian optimization library for materials science. Mater Discov. 2016;4:18–21.
Rasmussen CE, Williams CKI. Gaussian processes for machine learning. Cambridge, Mass: MIT Press; 2006.
Yang Z, Smola AJ, Song L, Wilson AG. A la Carte-Learning Fast Kernels, in: Proc 18th Int Conf Artif Intell Stat. 2015;1098–1106.
Kingma D, Ba J. Adam: A method for stochastic optimization. arXive:1412.6980. 20.
Kendal GP, Matthew GH. Determination of the tensile strength of elongated tablets. Powder Technol. 2013;238:169–75.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sano, S., Kadowaki, T., Tsuda, K. et al. Application of Bayesian Optimization for Pharmaceutical Product Development. J Pharm Innov 15, 333–343 (2020). https://doi.org/10.1007/s12247-019-09382-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12247-019-09382-8